Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals

English version České info

Here we assessed correlates of protection from disease progression in a rare subset of HIV-infected individuals, viremic non-progressors (VNP). These individuals have high viral load for several years. In contrast to the majority of infected individuals, however, these individuals do not progress to AIDS. Here we found this lack of progression was associated with selective preservation of two critical subsets of memory CD4+ T cells, central memory (TCM) and stem-cell memory (TSCM) cells. Compared to HIV-infected putative progressors, VNPs had higher proliferation of these indispensable subsets of memory cells. In addition, the long-lived CD4+ TCM and TSCM cells in VNPs had decreased HIV infection compared to the less critical effector memory CD4+ T cells, which indicates a possible mechanism by which VNPs maintain their CD4+ T cell pool after several years of infection, and remain free from AIDS progression.

Vyšlo v časopise: Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals. PLoS Pathog 10(8): e32767. doi:10.1371/journal.ppat.1004345
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004345

Souhrn

Zdroje

1. DeeksSG, WalkerBD (2007) Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy. Immunity 27: 406–416.

2. SodoraDL, SilvestriG (2008) Immune activation and AIDS pathogenesis. AIDS 22: 439–446.

3. PaiardiniM, CervasiB, DunhamR, SumpterB, RadziewiczH, et al. (2004) Cell-cycle dysregulation in the immunopathogenesis of AIDS. Immunol Res 29: 253–268.

4. CohenOJ, KinterA, FauciAS (1997) Host factors in the pathogenesis of HIV disease. Immunol Rev 159: 31–48.

5. CasadoC, ColomboS, RauchA, MartinezR, GunthardHF, et al. (2010) Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS One 5: e11079.

6. CaoY, QinL, ZhangL, SafritJ, HoDD (1995) Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection. N Engl J Med 332: 201–208.

7. HarrerT, HarrerE, KalamsSA, ElbeikT, StapransSI, et al. (1996) Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses 12: 585–592.

8. PantaleoG, MenzoS, VaccarezzaM, GraziosiC, CohenOJ, et al. (1995) Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332: 209–216.

9. DescoursB, Avettand-FenoelV, BlancC, SamriA, MelardA, et al. (2012) Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin Infect Dis 54: 1495–1503.

10. MiguelesSA, ConnorsM (2010) Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA 304: 194–201.

11. PotterSJ, LacabaratzC, LambotteO, Perez-PatrigeonS, VingertB, et al. (2007) Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J Virol 81: 13904–13915.

12. ElrefaeiM, McElroyMD, PreasCP, HohR, DeeksS, et al. (2004) Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol 173: 2184–2189.

13. KlattNR, SilvestriG (2012) CD4+ T Cells and HIV: A Paradoxical Pas de Deux. Science Translational Medicine 4: 123ps124.

14. RotgerM, DalmauJ, RauchA, McLarenP, BosingerSE, et al. (2011) Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 121: 2391–2400.

15. ChoudharySK, VrisekoopN, JansenCA, OttoSA, SchuitemakerH, et al. (2007) Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 81: 8838–8842.

16. CurriuM, Fausther-BovendoH, PernasMa, MassanellaM, CarrilloJ, et al. (2012) Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function. PLoS One 7: e30330.

17. BallanaE, Ruiz-de AndresA, MotheB, Ramirez de ArellanoE, AguilarF, et al. (2012) Differential prevalence of the HLA-C – 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals. Immunobiology 217: 889–894.

18. ShawJM, HuntPW, CritchfieldJW, McConnellDH, GarciaJC, et al. (2013) Short communication: HIV(+) viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses 29: 172–177.

19. HerspergerAR, PereyraF, NasonM, DemersK, ShethP, et al. (2010) Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 6: e1000917.

20. KlattNR, SilvestriG, HirschV (2012) Nonpathogenic simian immunodeficiency virus infections. Cold Spring Harb Perspect Med 2: a007153.

21. KlattNR, ChomontN, DouekDC, DeeksSG (2013) Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev 254: 326–342.

22. BuzonMJ, SunH, LiC, ShawA, SeissK, et al. (2014) HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med 20: 139–142.

23. LugliE, DominguezMH, GattinoniL, ChattopadhyayPK, BoltonDL, et al. (2013) Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest 123: 594–599.

24. CartwrightEK, McGaryCS, CervasiB, MicciL, LawsonB, et al. (2014) Divergent CD4+ T Memory Stem Cell Dynamics in Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections. J Immunol 192: 4666–4673.

25. PaiardiniM, CervasiB, Reyes-AvilesE, MicciL, OrtizAM, et al. (2011) Low levels of SIV infection in sooty mangabey central memory CD(4)(+) T cells are associated with limited CCR5 expression. Nat Med 17: 830–836.

26. HechtFM, BuschMP, RawalB, WebbM, RosenbergE, et al. (2002) Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16: 1119–1129.

27. GiorgiJV, HultinLE, McKeatingJA, JohnsonTD, OwensB, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859–870.

28. BrenchleyJM, HillBJ, AmbrozakDR, PriceDA, GuenagaFJ, et al. (2004) T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 78: 1160–1168.

29. PatelVP, KreiderBL, LiY, LiH, LeungK, et al. (1997) Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 185: 1163–1172.

30. LeeYS, WonKJ, ParkSW, LeeHW, KimB, et al. (2012) Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2. Cell Immunol 279: 1–11.

31. SchreiberTH, PodackER (2013) Immunobiology of TNFSF15 and TNFRSF25. Immunol Res 57: 3–11.

32. JinJ, YuQ, HanC, HuX, XuS, et al. (2013) LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition. Nat Commun 4: 2075.

33. SubramanianA, TamayoP, MoothaVK, MukherjeeS, EbertBL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.

34. RodgerAJ, FoxZ, LundgrenJD, KullerLH, BoeseckeC, et al. (2009) Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 200: 973–983.

35. LichtfussGF, HoyJ, RajasuriarR, KramskiM, CroweSM, et al. (2011) Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection. Biomark Med 5: 171–186.

36. ChahroudiA, BosingerSE, VanderfordTH, PaiardiniM, SilvestriG (2012) Natural SIV hosts: showing AIDS the door. Science 335: 1188–1193.

37. ChomontN, El-FarM, AncutaP, TrautmannL, ProcopioFA, et al. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15: 893–900.

38. DouekDC, BrenchleyJM, BettsMR, AmbrozakDR, HillBJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95–98.

39. GrovesKC, BibbyDF, ClarkDA, IsaksenA, DeaytonJR, et al. (2012) Disease Progression in HIV-1-Infected Viremic Controllers. J Acquir Immune Defic Syndr 61: 407–416.

40. McGaryCS, CervasiB, ChahroudiA, MicciL, TaaffeJ, et al. (2014) Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques. J Virol 88: 4533–4542.

41. SchindlerM, MunchJ, KutschO, LiH, SantiagoML, et al. (2006) Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055–1067.

42. OkoyeA, Meier-SchellersheimM, BrenchleyJM, HagenSI, WalkerJM, et al. (2007) Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204: 2171–2185.

43. JanssenRS, SattenGA, StramerSL, RawalBD, O'BrienTR, et al. (1998) New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280: 42–48.

44. KotheD, ByersRH, CaudillSP, SattenGA, JanssenRS, et al. (2003) Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 33: 625–634.

45. HatanoH, Vivek JainV, HuntP, LeeT, SinclairH, et al. (2013) Cell-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1 Expressing CD4+ T cells. J Infect Dis 208: 50–56.

46. KlattNR, VintonCL, LynchRM, CanaryLA, HoJ, et al. (2011) SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. Blood 118: 5803–5812.

47. BosingerSE, LiQ, GordonSN, KlattNR, DuanL, et al. (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. The Journal of Clinical Investigation 119: 3556–3572.